AC Immune SA financial data

Symbol
ACIU on Nasdaq
Industry
Pharmaceutical Preparations
Location
Epfl Innovation Park, Building B, 1015 Lausanne, Switzerland
State of incorporation
Switzerland
Fiscal year end
December 31
Latest financial report
6-K - Q2 2024 - Aug 6, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 99.2M shares +18.6%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 17.1M CHF +25.3%
General And Administrative Expense 4.55M CHF +23.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 238M CHF +52%
Liabilities 114M CHF +575%